Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company
  • 2019: ANNOUNCEMENT: BMSystems will be participating to Neurology Drug Development Europe and Polepharma (the N°1 pharmaceutical cluster in Europe) events: Alzheimer's Disease recurrent failures: A causal CADI™ model explains 14 key disease components!
  • 2019: PRESS-RELEASE: Paris April  2, 2019: Bio-Modeling Systems, the 14 M€ H2020 GEMMA (Autism and Microbiota) integrative biology partner, announces the release of the public program web site: for the World Autism Awareness Day.
  • 2019-NEW-YEAR PROGRAM: Paris January 24, 2019: In 2019, our founding motto: “Understand disease mechanisms first. Adapted treatments will follow.” is still highly relevant. FRENCH

  • 2018: POSITION PAPER : Paris December 2, 2018: SMART STRATEGY vs. BIG STRATEGY: How Augmented Intelligence, the other AI, addresses the digital “garbage in garbage out” reality and the life complexity

  • 2018: ANNOUNCEMENT: BMSystems invited to present its CADI Discovery platform and achievements at 4 events in Europe,BioFit,-BioWin-Day,COST EC cluster conference, DGA BtoB  

  • 2018: PRESSE-RELEASE: L’Association Française du Syndrome de Fatigue Chronique (AFSC) change les règles du jeu et s’associe à Bio-Modeling Systems pour développer et valider un modèle explicatif et thérapeutique de l'EM/SFC (CFS/ME).

  • 2018: PRESS-RELEASE: Paris October 10, 2108: Bio-Modeling Systems, with its operational CADI™ Discovery platform, is the Integrative Biology partner of GEMMA (autism & microbiota) project selected for €14.2M H2020 funding by the European Commission to identify potential targets for the personalized treatment and prevention of Autism Spectrum Disorderss

  • 2018: PRESS-RELEASE: Paris 10 Octobre 2108: Bio-Modeling Systems, avec sa plateforme opérationnelle CADI™ Discovery est le partenaire « Biologie Intégrative » du  programme GEMMA (autisme & microbiote) sélectionné par la Commission européenne pour un financement H2020 de 14,2 millions d'euros afin d'identifier des cibles potentielles pour le traitement personnalisé et la prévention des troubles du spectre autistique

  • 2018: ANNOUNCEMENT: Paris September 4, 2018: How CADI Discovery, invented in 2004,  successfully addressed the "Garbage in Garbage out" Law of every Data Processing explained in Current Opinion in Pharmacology:  How scientific literature analysis yields innovative therapeutic hypothesis through integrative iterations.
  • 2018: PRESS-RELEASE: Paris  July17, 2018: World's first: The French Chronic Fatigue Syndrome Association decides to clinically evaluate the ME/CFS pathogenesis model produced by Bio-Modeling System.s

  • 2018: ANNOUNCEMENT: Paris June 19-20, 2018: BMSystems invited to the Microbiotes conference organized by Adebiotech to present its microbiota vision and CADI Discovery programs. 

  • 2018: ANNOUNCEMENT: Paris June 14, 2018: BMSystems invited to the Connected Health Conference organized by ANRT to present its Real life data strategy with its "patients & HCP digital pathways" partner Bolero.

  • 2018: ANNOUNCEMENT: Paris March 13-14, 2018: BMSystems invited to the Epigentic conference organised by Adebiotech to present its CADI Discovery program EPIGEN-DIAB with the Centrer of excelllence in Epigenetic in India.
Bio-Modeling Systems: The Mechanisms-Based Mecidicine Companys

BMSystems Professional Network

BMSystems expertise recognition: Memberships in prestigious international scientific, professional and evaluation committees

  • Member: Evaluation committee of the funding priorities in the "Medical Systems Biology- MedSys" program, German Federal ministry of Research Berlin (2008-) .
  • Expert Systems biology for the European Commission DG Research (2011-).  
  • Member: Scientific Committee of the Cambridge Healthtech Institute. The world leading scientific conferences organizer USA (2005-).
  • Member: Wellcome Trust's Board of Experts, Systems Biology. The world's largest medical research charity funding research into human and animal health U. K. (2001-).
  • Elected Member: Human Genome Organization (HUGO) (USA) (1994-).
  • Overseas Fellow: Medical Research Council (MRC) U.K. (1989-).
  • Member: Biotechnology Industry Organization (BIO) USA (2008-).

BMSystems expertise recognition: Memberships in prestigious national scientific, professional and evaluation committees

  • President: Centrale-Santé Leading healthcare and biotech Think Tank in France (1996-).
  • President Adebiotech:Leading biotech (scientific) Association in France (2006-).
  • Vice-President: Leem Biotech;  Biotech group of the pharma industry association in France (2003-).
  • Executive Committee member: Medicen Paris Region: "World class" healthcare and biotech cluster.
  • Member: Systematic Paris Region:"World class" French Information & Communication Technologies Cluster .
  • Member: Biotech-Pharma; The Association of the Bio-Pharma industry operating in France (Amgen, Actelion, Serono, Biogen-Idec, Gilead, Genzyme).
  • Educational contribution: Ecole Supérieure de Physique et Chimie Industrielle ESPCI).
  • Educational contribution: INSERM.
Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology Mechanisms-Based Medicine company that delivers body> body> body> body> body> body> body>